The 2027 Financial Health Checklist for Cannabis Operators - Grab Your Seat for the Free Webinar Now!
The 2027 Financial Health Checklist for Cannabis Operators - Grab Your Seat for the Free Webinar Now!
Tag: CBT > DEA Cannabis Policy and Legalization | Cannabis Business Times
Subscribe
Sign In
Tag: CBT > DEA Cannabis Policy and Legalization: Page 6
Legislation and Regulation
Industry Weighs in on DEA Cannabis Research Final Rule
Stakeholders express concern that the agency will weigh applicants’ compliance with federal law when granting registrations.
December 23, 2020
Dispensary
Key Congressional Committee Advances Legislation to Facilitate Clinical Research Studies Using State-Authorized Marijuana Products
Members of the House Energy and Commerce Committee have voted in favor of a substitute version of Congressman Earl Blumenauer's HR 3797: The Marijuana Research Act of 2019.
September 14, 2020
Interviews & Opinion
Federal Government Sues California Bureau of Cannabis Control for Business Records
The DEA and DOJ have requested specific information about three state-licensed cannabis operators as part of a criminal investigation, and the BCC has refused to provide the information.
August 12, 2020
Legislation and Regulation
Reflecting on How Cannabis Legalization Can Help Stop Oppressive Policing and Foster Racial Justice
A letter from Marijuana Policy Project Executive Director Steve Hawkins.
June 5, 2020
Legislation and Regulation
U.S. House Includes SAFE Banking Act in New COVID-19 Relief Bill, Montana Cannabis Legalization Campaign Launches Signature Drive: Week in Review
This week, House lawmakers included legislative language from the SAFE Banking Act in new legislation aimed at economic relief amid the coronavirus pandemic.
May 16, 2020
Compliance
NCIA Calls for Cannabis Oversight Change
In comments to the DEA’s request for information, NCIA advises cannabis research be overseen by health agency.
May 13, 2020
Interviews & Opinion
Inside the DEA’s New Promise to Expand Cannabis Cultivation for Research
The Drug Enforcement Administration’s draft rules for the program have been met with mixed industry reactions, but Colorado-based MedPharm is encouraged by the progress.
April 24, 2020
Legislation and Regulation
USDA Releases Interim Hemp Regulations, Massachusetts Governor Pursues Emergency Regulation for Vape Ban: Week in Review
Now that the White House Office of Management and Budget has given the go-ahead to the USDA’s federal hemp regulations, the draft of interim rules for the industry is live.
November 2, 2019
Legislation and Regulation
Federal Court Dismisses Lawsuit Against DEA Over Medical Cannabis Research
The DEA announced in August that it would expedite the review of cultivation license applications that have been pending for three years, making the lawsuit “moot,” according to the judge.
October 30, 2019
Legislation and Regulation
Senate Committee Hearing Emphasizes the Need for Policy Change to Increase Cannabis Research Access
This week, Senators Feinstein and Cornyn convened a panel of leading health experts to uncover the health impact of cannabis on consumers. Instead, they were hit with the realization that the only way to determine those impacts is through increased research access.
October 25, 2019
Colorado
Colorado-Based MedPharm Has Big Plans for Cannabis Research
The DEA has notified the company that it has been chosen to advance in the licensing process to grow federally legal cannabis for research purposes.
September 4, 2019
Legislation and Regulation
DEA Announces Cannabis Research Expansion Plans, Washington Eyes Bill Allowing Growers to Deliver: Week in Review
The DEA has pledged to take steps to approve additional federal cultivation licenses from a pool of applications that have been pending for nearly three years.
August 31, 2019
Previous Page
Page 6 of 8
Next Page